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Available online 9 March 2012Differentiation of insulin producing beta-cells is a genetically well deﬁned process that involves functions of
various conserved transcription factors. Still, the transcriptional mechanisms underlying speciﬁcation and
determination of beta-cell fate are poorly deﬁned. Here we provide the description of a beta-cell progenitor
speciﬁc enhancer as a model to study initial steps of beta-cell differentiation. We show that evolutionary non-
conserved upstream sequences of the zebraﬁsh hb9 gene are required and sufﬁcient for regulating expression
in beta-cells prior to the onset of insulin expression. This enhancer contains binding sites for paired-box tran-
scription factors and two E-boxes that in EMSA studies show interaction with Pax6b and NeuroD, respective-
ly. We show that Pax6b is a potent activator of endodermal hb9 expression and that this activation depends
on the beta-cell enhancer. Using genetic approaches we show that pax6b is crucial for maintenance but not
induction of pancreatic hb9 transcription. As loss of Pax6b or Hb9 independently results in the loss of insulin
expression, the data reveal a novel cross-talk between the two essential regulators of early beta-cell differen-
tiation. While we ﬁnd that the known pancreatic E-box binding proteins NeuroD and Ngn3 are not required
for hb9 expression we also show that removal of both E-boxes selectively eliminates pancreatic speciﬁc re-
porter expression. The data provide evidence for an Ngn3 independent pathway of beta-cell speciﬁcation
that requires function of currently not speciﬁed E-box binding factors.
© 2012 Elsevier Inc.Open access under CC BY-NC-ND license. Introduction
The Hb9/Hlxb9/Mnx1 gene encodes a homeobox transcription fac-
tor that in vertebrates has conserved functions in motoneuron differ-
entiation and pancreas development (Broihier and Skeath, 2002;
Ferrier et al., 2001; Grapin-Botton et al., 2001; Tanabe et al., 1998;
Wendik et al., 2004). Furthermore, in humans, the heterozygous
loss of HLXB9 function is the major cause for sacral agenesis in pa-
tients with Currarino syndrome (Ross et al., 1998). Consistent with
these diverse functions, Hb9 genes in all vertebrates show a complex
pattern of expression that is conserved in motoneurons, pancreatic
endoderm, differentiating beta-cells and different mesodermal struc-
tures including the posterior notochord (Harrison et al., 1999; Li and
Edlund, 2001; Li et al., 1999; Ross et al., 1998; Saha et al., 1997;
Tanabe et al., 1998; Thaler et al., 1999; Wendik et al., 2004). Whileology, University of Innsbruck,
50728.
,
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ac.be (B. Peers),
nd Prosche Ring 17, D-63110
NC-ND license.Hb9 genes have been subject to various promoter studies (Lee et al.,
2004; Nakano et al., 2005; Woolfe et al., 2005), not much is known
about the molecular mechanism underlying their complex regulation.
Previous studies focused on highly conserved non-coding sequence
motifs identiﬁed in comparative genome promoter studies. The con-
servation is most striking in two 5 prime sequences, a distal 320 bp
motif termed the A-box and a more proximal motif of about 150 bp
termed the B-box (Nakano et al., 2005) (Fig. 1A). As these motifs
show 74–94% identity in diverse species such as zebraﬁsh and
human it was suggested that they might have functions in gene reg-
ulation. Consistent with this notion, studies in mouse showed that
the B-box and a second more proximal, mammalian-speciﬁc con-
served motif termed MNE are sufﬁcient and required for targeting re-
porter expression to motoneurons (Lee and Pfaff, 2003; Lee et al.,
2004; Nakano et al., 2005). However, sequence motifs related to
MNE have not been detected outside of mammals (Lee and Pfaff,
2003; Lee et al., 2004; Nakano et al., 2005) and mechanisms underly-
ing hb9 regulation in non-mammalian organisms and in endodermal
and mesodermal structures remain to be investigated.
Here we use the zebraﬁsh as a model to study hb9 regulatory ele-
ments with a focus on pancreas-speciﬁc regulation. Hb9 genes in zeb-
raﬁsh and mouse are expressed during two distinct phases of
pancreas development (Harrison et al., 1999; Li et al., 1999; Wendik
 
Fig. 1.Motoneuron and beta-cell speciﬁc GFP expression in Tg[hb9:GFP]ml2 embryos. (A) Schematic representation of the hb9 gene from different species. Highlighted are conserved
non-coding regions (dark green), and exons (coding sequences in grey, untranslated regions in blue). (B–I′) In situ hybridization analysis comparing mRNA expression of hb9 (B, D,
D′) and gfp (C, E, E′) in Tg[hb9:GFP]ml2 embryos at 17 hpf (B, C) and 24 hpf (D, E) reveals similar pattern in motoneurons and ventral interneurons (B–E, white arrows) and pancreas
(B, C, white arrowheads). Asterisk in C marks ectopic gfp expression in rhombomere. D′, E′ show different focal planes of the embryos shown in D, E. (F–I) Confocal image projec-
tions of Tg[hb9:GFP]ml2 embryos labelled with GFP (green) and islet antibodies (red) at 16 hpf (F), 19 hpf (G) and 24 hpf (H) show overlapping expression of GFP and islet proteins
in motoneurons (arrows) and in a subset of endocrine cells (arrowheads). (H–I′) Confocal image stacks of Tg[hb9:GFP]ml2 embryos labelled with antibodies for GFP and pancreatic
hormones at 24 hpf (H′) and 48 hpf (I, I′) show that GFP overlaps with insulin (blue in H′, I) but not with glucagon (Glu) and somatostatin (Sst) (Glu+Sst in red, I′). Embryos are
shown in dorsal (B–E) or ventral (F–I) view with anterior to the left. Scale bars in all ﬁgures correspond to 50 μm.
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expressed in the entire prospective pancreatic endoderm. With the
onset of organ morphogenesis, expression is ﬁrst downregulated
and later reactivated speciﬁcally in differentiating beta-cells. Knock-
out studies in mouse revealed independent requirements for the
early and late pancreatic Hb9 expression in initiating pancreas mor-
phogenesis and in regulating beta-cell maturation, respectively. In
particular, one of the pancreatic anlagen, the dorsal bud, is missing
in the mutants and the second, ventral bud, is formed but fails to es-
tablish mature beta-cells as revealed by reduced expression of the
early beta-cell differentiation marker insulin and loss of the late dif-
ferentiation marker Glut2 (Harrison et al., 1999; Li et al., 1999). In
zebraﬁsh, morpholino knock down of hb9 results in a strong reduc-
tion or even loss of embryonic insulin expression while early pancreas
morphogenesis appears unaffected (Wendik et al., 2004). The datasuggest that only the later beta-cell speciﬁc expression of hb9 is asso-
ciated with an evolutionary conserved function in beta-cell differenti-
ation and maturation. Consistent with the requirement for hb9
upstream of insulin, the onset of hb9 expression in beta-cells precedes
that of insulin (Wendik et al., 2004). This makes hb9 one of the earli-
est speciﬁc markers for differentiating beta-cells and suggests that
hb9 expression is linked with initial steps of beta-cell speciﬁcation.
Beta-cell formation requires activities of a conserved network of
cross-regulating transcription factors which interact during pancreas
development to establish the characteristic expression programmes
for the distinct pancreatic cell types (Edlund, 2002; Habener et al.,
2005; Kinkel and Prince, 2009; Schwitzgebel, 2001; Wilson et al.,
2003). Genetic studies in mouse identiﬁed more than a dozen tran-
scription factors that contribute to this network and that are required
for proper differentiation of beta-cells. So far only a few of these
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opment. Among these, the homeobox-containing proteins Nkx6.1 and
Nkx6.2 are required for deﬁning a beta-cell progenitor pool (Binot et
al., 2010), while Nkx2.2a and Pax6b are essential for beta-cell fate de-
termination (Pauls et al., 2007; Verbruggen et al., 2010). Ngn3/Neu-
rog3, a basic helix–loop–helix (bHLH) factor that in mouse is a key
regulator of endocrine cell differentiation was reported to be
expressed in the larval but not the embryonic zebraﬁsh pancreas
(Apelqvist et al., 1999; Gradwohl et al., 2000; Jenny et al., 2002;
Kinkel and Prince, 2009; Moro et al., 2009; Rukstalis and Habener,
2009; Schwitzgebel et al., 2000; Zecchin et al., 2007). The bHLH factor
NeuroD/Beta2, that is expressed, similar to the situation in mouse
(Huang et al., 2002; Itkin-Ansari et al., 2005; Naya et al., 1997), in
all endocrine precursors, was found to be missing in nkx6.1/nkx6.2
double morphants (Binot et al., 2010) and reduced in nkx2.2a single
morphant zebraﬁsh embryos (Pauls et al., 2007). Notably, reduction
of neuroD expression in these morphants correlates with the loss of
insulin expression, which is consistent with a possible function of
NeuroD in beta-cell fate determination downstream of the nkx genes.
We have previously generated a hb9:GFP transgenic zebraﬁsh line
Tg[hb9:GFP]ml2 (also known as Tg[mnx1:GFP]ml2) in which 3.1 kb of
hb9 genomic sequences, including the A- and B-box, are sufﬁcient
to recapitulate several aspects of hb9 expression (Flanagan-Steet et
al., 2005; Kimmel and Meyer, 2010). In contrast to the currently
available Hb9 mouse promoter lines (Arber et al., 1999; Nakano et
al., 2005; Thaler et al., 1999; Wichterle et al., 2002), these ﬁsh also
show reporter expression in the pancreas, speciﬁcally recapitulating
the functionally conserved hb9 expression in beta-cells. Here we pro-
vide the ﬁrst characterization of an hb9 beta-cell enhancer element
and of upstream transcription factors mediating the beta-cell speciﬁc
expression. We show that in zebraﬁsh the hb9 beta-cell enhancer el-
ement localizes to 478 bp of non-conserved distal sequences and we
provide molecular and genetic evidence for a direct binding of the
endocrine progenitor factors NeuroD and Pax6b on this element.
Our data reveal distinct functions of the 478 bp motive in establish-
ing and maintaining beta-cell speciﬁc expression, further indicating
that the hb9 pancreas enhancer represents a promising model for de-
tailed analyses of the molecular regulation of beta-cell fate speciﬁca-
tion and determination.
Materials and methods
Transgenic lines and ﬁsh maintenance
The Tg[ins:dsRed] transgenic line (Shin et al., 2008) was used for
injection of DNA constructs. AB strain and Tg[hb9:GFP]ml2 transgenic
line were used for mRNA and morpholino injections. The pax6bsa0086
allele (Verbruggen et al., 2010) was obtained from the Sanger Center.
DNA constructs and promoter analysis
The zebraﬁsh hb9 promoter fragments were initially isolated
from PAC clones that were identiﬁed by hybridizing with a radioac-
tive labelled hb9 cDNA. Southern analysis of the PAC DNA revealed
the presence of the 5′ UTR of hb9 on a 5.3 kb EcoRI fragment. This
fragment was sub-cloned into pBluescript and sequenced on an
ABIPrism 310 Genetic Analyzer (ABI Prism® BigDye™ Terminator,
Applied Biosystems). Sequencing of the ampliﬁed hb9 promoter
revealed an 8 bp deletion at −1558 bp and 2 substitutions at
−1046 and −717. Conserved promoter regions of the hb9 gene
were identiﬁed by comparing the zebraﬁsh, mouse, human, chick
and Fugu locus by BLAST searches (http://blast.ncbi.nlm.nih.gov/
Blast.cgi) and ClustalW2 Multiple Sequence Alignment (http://
www.ebi.ac.uk/Tools/msa/clustalw2/). Potential binding sites were
identiﬁed by Match-1.0 Public, Patch 1.0 and P-Match-Public 1.0
Public programmes (www.gene-regulation.com).hb9pG1 vector was generated by cloning the 3.1 kb hb9 promoter
into the pG1 vector (Gilmour et al., 2002) by using EcoRI/BamHI re-
striction enzymes. The hb9-deletion constructs were generated
based on hb9pG1 vector by using the indicated restriction enzymes.
hb9NheI:GFP_pG1 was generated by introducing a NheI restriction site
into the PE/A-box boundary with the Site-Directed Quick-Change Mu-
tagenesis Kit (Stratagene). From this constructs hb9ΔNheI:GFP and
hb9ΔA:GFP were generated by cutting with EcoRI/NheI and NheI/EagI
respectively and blunting with T4 Polymerase (Fermentas, EP0061)
and religation. For generation of hb9Δ1:GFP and hb9Δ2:GFP constructs
PCR was used to amplify the desired elements and PCR-fragments
were cloned upstream of A-Box into hb9NheI:GFP_pG1. hb9Δ1:GFP was
generated with hb9_EcoRI_F (GAATTCCTGAGGAAAACGCTTTCG) and
NheI_R (TCGATCATGCTAGCACAAATGGGCCGTGC) primers, hb9Δ2:GFP
was generated with SalI_F (GTCGACATTTAAATTAGCCTGGCATCTGG)
and dr_hb9_NheI_R (GCTAGCCAGTTTGCTTTGATAAGCC) primers.
Quick-Change Mutagenesis Kit (Stratagene) was used for the gener-
ation of hb9Em:GFP. The following primers were used: NrD_mut_F
(CATTTAAATTAGCCTGGAGATCTGACATCGTCAATCACG), NrD_mut_R
(CGTGATTGACGATGTCAGATCTCCAGGCTAATTTAAATG), E47mut_F
(GTGTTCGGTTAAGTAAACTAGTGTTTTCGGGCTGGTTC) and E47mut_R
(GAACCAGCCCGAAAACACTAGTTTACTTAACCGAACAC).
For generation of hb9PE229:gfp DNA the PE229 fragment was PCR-
ampliﬁed by using SalI_F and NheI_R primers and cloned into
hb9pG1, linearized with SalI/StuI. For generation of hb9ΔAB:GFP plas-
mid hb9NheI:GFP_pG1 was digested with NheI/StuI and religated. For
cloning of reporter vectors PE+hsp:GFP, A+hsp:GFP and PE+A+hsp:
GFP zebraﬁsh hsp70 promoter was ﬁrst ampliﬁed by PCR with the fol-
lowing primers: hsp70_StuI_F (AGGCCTTCAGGGGTGTCGCTTGGT)
and hsp70_BamHI_R (GGATCCTTGTACAAACTTGGCAGGAA). PE+hsp:
GFP construct was generated by cloning hsp70 PCR fragment into
hb9NheI:GFP_pG1 after cutting of last with NheI/BamHI and blunt of
NheI-site. For generation of A+hsp:GFP hsp70 was cloned into
hb9ΔNheI:GFP_pG1 after serial cutting with AvrII/BamHI and blunt of
AvrII site. For generation of PE+A+hsp:GFP reporter construct hsp-
PCR fragment was cloned into hb9pG1 after digest with AvrII/
BamHI. Before injection promoters, except vectors showed on Fig. 3,
A, were cloned into pT2KXIG (Kawakami, 2004) vector by restriction
with XhoI/BamHI (vector) and SalI/BamHI (promoter).
Generation of transgenic zebraﬁsh
Tg[hb9:GFP]ml2 transgenic line was generated as described by
Flanagan-Steet et al. (2005). For microinjection of hb9:GFP, hb9ΔA:
GFP, hb9ΔNheI:GFP, hb9Δ1:GFP, hb9Δ2:GFP, hb9PE229:GFP, hb9ΔAB:GFP,
PE+hsp:GFP, A+hsp:GFP, PE+A+hsp:GFP and hb9Em:GFP constructs
the intact Tol2 vectors, containing corresponding hb9 promoter
were injected into 1-cell stage Tg[ins:dsRed] zebraﬁsh embryos to-
gether with transposase mRNA. GFP-positive embryos were raised to
adulthood and screened for transgene transmission to their progeny.
Microinjection of DNA, mRNA and morpholinos
For microinjection of constructs shown on Fig. 3, A, DNA were
linearized with NotI and puriﬁed DNA were injected into one-cell
stage zebraﬁsh embryos. Knock-down experiments were performed
with published splicing morpholinos against pax6b (Mo2Pax6b
(in this text called MOpax6b), 5′-TTGATTTGCACTCACGCTCGGTATG)
(Verbruggen et al., 2010), ATG morpholino for neuroD (nrdMO)
(in this text called MOneuroD: TGACTTCGTCATGTCGGAACTCTAG)
(Sarrazin et al., 2006), and ATG morpholino for ngn3 (MOngn3:
GGATCTTGGAGTCATTCTCTTGCAA). Morpholino was injected into
1-cell stage AB-strain or Tg[hb9:GFP]ml2 zebraﬁsh embryos.
For induction experiments single-cell injection was performed at
16–32 cell stage in AB-strain, Tg[hb9:GFP]ml2 and Tg[hb9ΔNheI:GFP].
The following mRNA were injected: Casanova (cas_pCS2+), nucRFP
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HA_pCS2+) and NeuroD-Flag (NeuroD-Flag_pCS2+). For mRNA syn-
thesis vectors were restricted with NotI and mRNA was produced by
using Sp6 mMessage mMachine Kit, Ambion.
EMSA
The following oligos were used for EMSA (only forward primers
are listed, reverse primers present the same sequence but reverse
and complement):
E1 (CATTTAAATTAGCCTGGCATCTGGACATCGTCAATCACG)
E1m (CATTTAAATTAGCCTGGAGATCTGACATCGTCAATCACG)
E2 (GTGTTCGGTTAAGTAACACCTGGTTTTCGGGCTGGTTC)
E2m (GTGTTCGGTTAAGTAAACTAGTGTTTTCGGGCTGGTTC)
P1+2+3 (GCATCTGGACATCGTCAATCACGGGCTCGTGACACCGAG)
P4+5+6
(AGAGGGGACTCGTGGGTCATCTCGTTTAAAGCGCATTTTAAATTAC)
P7+8
(TGTGTTCGGTTAAGTAACACCTGGTTTTCGGGCTGGTTCATCAGT)
P9+10 (TGAATCACTTAAGAGATAATCAGGCTTATCAAAGC)
P11 (ACTTTGTATTATGCAATGTTTTCAAAA)
P12 (GAAAGGAAAAAGCATGAAGCACTGAATC)
P613 (GTGTCCTTTAATGACTTTTATAGTTGG)
P14 (CCCATTTGTGCAATTATGATCGAAAATATTTA).
EMSAwas performed according to a published protocol with some
modiﬁcations (Hartl et al., 2006). Oligos were end-labelled using
Adenosine 5′-triphosphate ([γ-32P], PerkinElmer) and polynucleotide
kinase (Fermentas, EK0031). Pax6b-HA protein and NeuroD-Flag/E47
complex were synthesised in vitro by TNT Quick-coupled Transcrip-
tion/Translation kit (Promega) using the following plasmids:
E47_pcDNA3 (obtained from S. Pfaff), Pax6b-HA_pCS2+, and NeuroD-
Flag_pCS2+. After oligo labelling and protein synthesis the binding re-
action was performed using 25,000 cpm for each oligo, 2 μl protein in
the presence of 0.1 mg/ml of poly(dI-dC) and 1× binding buffer (5×
buffer: 60 mM HEPES pH 7.9, 20 mM Tris–HCl pH 7.9, 300 mM KCl,
60% (v/v) glycerol, 5 mMDTT and 5 mM EDTA). The reaction was incu-
bated for 45 min at room temperature. For competition assays, the unla-
belled competitors were added at a 100-fold higher concentration and
incubated at room temperature for 15 min, then the labelled probes
were added and incubated for an additional 40 min. Binding was ana-
lysed by running a native 5% polyacrylamide gel, followed by overnight
exposure of ﬁlm (GE Healthcare, Amersham HyperﬁlmTM MP) at
−80 °C before development.
Whole-mount in situ hybridization and immunohistochemistry
Whole mount in situ hybridization using antisense RNA-probes la-
belled with digoxigenin (DIG) was performed as previously described
(Hauptmann and Gerster, 2000). The following probes were used: in-
sulin (obtained from W. Driever), hb9 (Wendik et al., 2004) and gfp
(pG1) (Gilmour et al., 2002). RNA probes were prepared by using
T7 or Sp6 RNA-Polymerases and DIG-Labelling Mix (Roche) according
to the supplied protocol. All probes were detected using Anti-
digoxygenin-AP FAB fragments (Roche).
For immunohistochemistry embryos were ﬁxed for 1 h at RT in 4%
PFA and 1% DMSO. After ﬁxation embryos were blocked with blocking
buffer for 1 h at RT and incubated with primary antibodies overnight
at +4 °C. The following day embryos were washed 3 times for 15 min
in 1× PBST and incubated in blocking buffer for 1 h at RT. Embryos
were then incubated with secondary antibodies overnight at +4 °C.
Blocking and staining solutions contained 1% sheep serum, 1% BSA,
1% triton X-100, and 1% DMSO in PBS. Primary antibodies: anti-GFP
(1: 200, rabbit IgG, Torrey Pines Biolabs), Islet-I Homeobox (1: 200,mouse IgG, 39.4D5, DSHB) and polyclonal guinea pig anti-insulin (1:
200, Dako), polyclonal rabbit anti-human glucagon (1:200, Dako)
and polyclonal rabbit anti-somatostatin (1:200, Dako); secondary an-
tibodies: Alexa Fluor 488 goat anti-rabbit IgG, Alexa Fluor 633 goat
anti-guinea pig IgG (1: 1000, Invitrogen) and mouse Goat IgG, Cy3-
conjugated (1:1000, Chemicon).
Imaging
Confocal image stacks were generated with Zeiss LSM Exciter5 mi-
croscope equipped with the following lasers: 25 mW Argon laser
(468, 488, 514 nm), 1 mW 543 nm HeNe-laser, 5 mW 633 nm
HeNe-laser and a 25 mW 405 nm diode-laser. Fluorescence detection
was performed with the following dichroic beam splitters and ﬁlters:
HFT405/488/543/633, NFT545, BP 505–530 (GFP and Alexa 488), LP
560 (Cy3) and LP 650 (Alexa 633). A Leica DM 6000 microscope
was used for DIC images of whole mount in situ staining. AdobePhoto-
shop was used for image arrangement and adjustment.
Results
3.1 kb of 5′ ﬂanking region of the zebraﬁsh hb9 gene contains motoneu-
ron and beta-cell speciﬁc regulatory elements
Tg[hb9:GFP]ml2 transgenic ﬁsh that contain 3.1 kb of 5 prime up-
stream non-coding region of the zebraﬁsh hb9 gene fused to the gfp
cDNA show GFP expression in motoneurons and in the pancreas. In
order to clarify whether the reporter expression recapitulates the en-
dogenous hb9 expression, we compared hb9 and gfp mRNA expres-
sion at different stages of development (Fig. 1, Supplemental Fig. 1).
Whole mount mRNA in situ hybridisation analyses of Tg[hb9:GFP]ml2
embryos between 10 and 24 h post fertilization (hpf) revealed simi-
larities but also differences between hb9 and gfp expression. In partic-
ular we found that gfp expression in Tg[hb9:GFP]ml2 does not
recapitulate hb9 expression in early endoderm, notochord, hypochord
and swim bladder and that gfp is expressed ectopically in various tis-
sues including hindbrain, eyes and anterior somites (Supplemental
Fig. 1). The differences in expression suggest that additional enhancer
and silencer elements outside the 3.1 kb fragment must contribute to
the complex hb9 expression. However, consistent with the expected
overlapping expression in motoneurons and beta-cells, we observed
similar patterns of robust gfp and hb9 expression in the spinal cord
and the primary pancreatic islet (Figs. 1B–E′). Immunoﬂuorescence
analyses of 12–24 somite stage Tg[hb9:GFP]ml2 embryos (16–24 hpf)
with an anti-islet antibody, a marker for primary neurons and pancre-
atic endocrine cells, conﬁrm that GFP is expressed in spinal motoneu-
rons (Fig. 1F) and in a subpopulation of the early endocrine cells
(Figs. 1F, G). To further deﬁne which endocrine cell types are expres-
sing GFP, we stained 24 hpf and 48 hpf Tg[hb9:GFP]ml2 embryos with
antibodies against insulin and with a mixture of the alpha and
delta-cell markers anti-glucagon and anti-somatostatin (Figs. 1H–I′).
Overlapping expression of GFP and insulin but not GFP and gluca-
gon/somatostatin at 48 hpf shows that pancreatic expression in Tg
[hb9:GFP]ml2 is speciﬁc to beta-cells (Figs. 1I, I′). In summary, this
shows that cis-regulatory enhancer elements controlling the highly
conserved hb9 expression in motoneurons and beta-cells are present
within the 3.1 kb of the 5 prime upstream non-coding region.
In sequence alignments of 5 prime Hb9 regions from zebraﬁsh,
fugu (Takifugu rubripes), chicken, mouse and human, the A-box and
B-box are found 2.6 and 2 kb upstream of ATG, respectively
(Fig. 1A). To localize the speciﬁc regulatory elements required for
pancreatic and motoneuron gene expression, we generated hb9:
GFP-reporter constructs lacking the A and/or B box and ﬂanking geno-
mic regions (Fig. 3A, Supplemental Fig. 2A), and analysed their activ-
ities in embryos injected with the corresponding DNA. Such transient
reporter assay results in mosaic F0 embryos in which only a small
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distribution of the injected DNA. To distinguish beta-cell speciﬁc
expression from potential nonspeciﬁc expression in the surround-
ing cells, the DNA constructs were injected into Tg[ins:dsRed] trans-
genic embryos in which beta-cells express dsRED, and analysed for
overlapping expression of GFP and dsRED. In independent control
injections with the 3.1 kb hb9:GFP construct, we observed GFP/
dsRED double labelled cells in 25–40% of the injected embryos
(Supplemental Figs. 2B–D). Motoneuron speciﬁc expression, as
judged by the presence of GFP labelled peripheral axonalFig. 2. Pancreas speciﬁc GFP expression in Tg[hb9:GFP] embryos requires distal non-conserv
results of the transient reporter assay (right, indicated are the numbers (n) of embryos sho
(B) Scheme of Tol2 hb9-reporter constructs (left) and results of transient reporter assays (r
positive beta-cell (P)). (C–G) GFP expression in representative transgenic lines at 28 hpf in
GFP (green), insulin (blue) and islet (red). The right panel shows confocal image projection
GFP expression is found for reporter constructs lacking either the A-box (Tg[hb9ΔA:GFP], C)
most distal 229 bp (Tg[hb9ΔNheI:GFP], D; Tg[hb9Δ1:GFP], E). Scale bar corresponds to 100 μm
pression in all transgenic reporter lines see Supplementary Table 1.projections, was observed in 80–100% of the embryos. No GFP ex-
pression could be observed after injection of constructs that were
either missing the A- and B-Box-containing distal half or that
were missing the proximal part between the B-box and HindIII re-
striction site (Fig. 2A, Supplemental Fig. 2A). Most importantly, GFP
expression in motoneurons was observed following injection of all
constructs containing proximal sequences together with the B-box,
while beta-cell speciﬁc GFP expression was only observed with
constructs that contained the most distal part including the A-box
(Fig. 2A, Supplemental Fig. 2A).ed hb9 promoter sequences. (A) Scheme of non-Tol2 hb9-reporter constructs (left) and
wing presence (+) or absence (−) of GFP signal in spinal cord (SC) and pancreas (P)).
ight, indicated are the numbers of GFP positive embryos (n) and of embryos with GFP
whole embryos (left panel) and in ﬁxed tissue (right panel) stained with antibodies for
s and the corresponding overlays (white asterisk in E marks a motor axon). Pancreatic
or the 249 bp ﬂanking the A-box (Tg[hb9Δ2:GFP], F), but not for constructs lacking the
(whole embryos) and 20 μm (confocal image stacks). For further details on the GFP ex-
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tifs can direct tissue speciﬁc hb9 expression in the pancreas andmoto-
neurons and the proximal non-conserved sequences seem to be
important either for basal expression or to enhance expression levels.
Furthermore, our analyses suggest a conserved role for the B-box in
regulating motoneuron speciﬁc expression and provide a ﬁrst hint
for the presence of an hb9 beta-cell speciﬁc enhancer distal to the B-
box.Fig. 3. 478 bp of proximal hb9 promoter sequences are sufﬁcient for beta-cell speciﬁc regu
constructs on the left and corresponding numbers of GFP positive embryos (n) and embryo
sentative transgenic lines at 28 hpf in whole embryos (left panel) and in ﬁxed tissue (right p
confocal image projections and the corresponding overlays (right-most panel). Scale bar c
details see also Supplementary Table 2.478 bp of non-conserved sequences are required and sufﬁcient for
beta-cell speciﬁc expression
To better characterize the beta-cell enhancer we next generated
constructs in which distal sequences were deleted (Fig. 2B). For
these experiments, we used Tol2-mediated transgenesis in order to
increase the likelihood of having beta-cell expression in our transient
assays and to enhance recovery of stable transgenic lines. Surprisingly,lation. (A) Overview of transient GFP reporter experiments with a scheme of deletion
s expressing GFP in the pancreas (P) on the right side. (B–F) GFP expression in repre-
anel) stained with antibodies for GFP (green) and insulin (blue). The right panel shows
orresponds to 100 μm (whole embryos) and 20 μm (confocal image stacks). For more
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sion in beta-cells as identiﬁed by insulin antibody staining. Analyses
of transiently expressing embryos revealed a similar frequency of
pancreas speciﬁc GFP expression for hb9ΔA:GFP and hb9:GFP con-
structs (Fig. 2B). To conﬁrm the transient expression data, we isolated
a total of 12 independent stable integrations for Tg[hb9ΔA:GFP] and 2
independent alleles for Tg[hb9:GFP] (Figs. 2C, D, Supplemental Table
1). From those, nine of the Tg[hb9ΔA:GFP] and both Tg[hb9:GFP]
showed robust GFP expression in beta-cells and in motoneurons
(Figs. 2C, D). The data suggest that the A-box is not required for pan-
creas and for motoneuron speciﬁc reporter expression. Notably, these
transgenic lines showed a highly variable reporter expression in gut
endoderm, epidermis, somites and nervous system, indicating that
our reporter constructs are strongly inﬂuenced by positional effects
(Supplemental Table 1).
The lack of beta-cell speciﬁc GFP expression in ΔAPstI:GFP transient
line (Fig. 2A) but not in hb9ΔA:GFP (Fig. 2B) suggests that the non-
conserved distal part of the 3.1 kb fragment must mediate beta-cell
speciﬁc expression. Consistent with this notion, we found that the
loss of the distal 478 bp in hb9ΔNheI:GFP injected embryos abolishes
beta-cell speciﬁc expression in transient reporter assays and also in
Tg[hb9ΔNheI:GFP] stable transgenic allele (Figs. 2B, E, Supplemental
Table 1). We therefore conclude that the non-conserved distal pro-
moter sequences contain essential elements for pancreas speciﬁc
expression.
To deﬁne the position of these elements more precisely, we gener-
ated constructs lacking either the distal or proximal halves of the non-
conserved sequences between −3097 and −2868 bp (hb9Δ1:GFP)
and between −2868 and −2619 (hb9Δ2:GFP), respectively (Fig. 2B).
In transient reporter assays, hb9Δ1:GFP DNA failed to induceFig. 4. In vitro binding of NeuroD and Pax6b to PE speciﬁc sequence motives. (A) Schematic
red) and Pax6 (blue) within the hb9 pancreas enhancer as revealed by bioinformatic sequen
and sites with a core match between 0.9 and 1 are shown in dark blue (core=TCACG). Ori
strand; below: negative DNA). (B) EMSA studies show binding of in vitro synthesized Neuro
corresponding oligonucleotides with mutated E boxes (E1m and E2m). Competitor assays wit
and E2 but not by E1m and E2m. Notably, unlabelled E2m reduced binding of labelled E2 to Ne
Bands indicated by the asterisk presumably correspond to monomeric DNA–protein comple
tides spanning individual or multiple potential Pax6b sites (as indicated). EMSA signals cou
sitions of protein-bound DNAs are indicated by arrowhead).pancreatic GFP expression (1.3% of the embryos showed overlapping
GFP and dsRED expression, n=149, Fig. 2B) while the hb9Δ2:GFP
(overlapping expression in 21% of embryos, n=63, Fig. 3B) induced
pancreas speciﬁc GFP expression, although the frequencywas reduced
as compared to the hb9:GFP control construct (43%, n=112, Fig. 2).
Results with stable transgenic lines were consistent with the transient
assays as 6 out of 7 Tg[hb9Δ1:GFP] alleleswere negative for GFP expres-
sion in the pancreas while 7 out of 10 Tg[hb9Δ2:GFP] alleles showed
speciﬁc expression in beta-cells (Figs. 2F, G, Supplemental Table 1).
To determine if the distal sequences are sufﬁcient to activate gfp
expression in beta-cells, we generated two constructs in which the
most distal 229 bp (hb9PE229:GFP) or 478 bp (hb9ΔAB:GFP) were di-
rectly fused to the proximal part of the hb9 promoter (Fig. 3A). Both
constructs induced pancreas speciﬁc expression in transient assays,
indicating that the distal sequences contain the pancreas enhancer.
However, in stable transgenic lines only Tg[hb9ΔAB:GFP] alleles
showed beta-cell speciﬁc GFP expression (Fig. 3C, Supplemental
Table 2). While four of the nine Tg[hb9PE229:GFP] alleles showed
weak expression in the pancreas, immunoﬂuorescence analyses
revealed that in three alleles GFP expression did not overlap with in-
sulin (Fig. 3B, Supplemental Table 2). These data suggest that the
most distal 229 bp are required but not sufﬁcient for beta-cell speciﬁc
gene expression. They further suggest that the 478 bp of non-
conserved distal hb9 sequences, that we hereafter refer to as PE, con-
tain multiple elements that together regulate beta-cell speciﬁc
expression.
We next asked if the distal 478 bp contain all sequence motifs suf-
ﬁcient for beta-cell speciﬁc expression. To answer this question, we
generated constructs in which the 478 bp PE fragment was cloned in
front of the zebraﬁsh hsp70 promoter linked to a gfp cDNA (PE+hsp:representation of potential binding sites for the transcription factors NeuroD (E-box in
ce analyses. Pax6 sites with a core match between 0.76 and 0.9 are shown in light blue,
entation of Pax6 sites is indicated by position relative to the line (above: positive DNA
D/E47 dimers (Prot) to oligonucleotides (DNA) spanning the E-boxes (E1, E2) but not to
h unlabelled oligonucleotides (comp, as indicated) revealed efﬁcient competition by E1
uroD/E47, suggesting that E2 binds NeuroD/E47 with lower afﬁnity as compared to E1.
xes. (C) EMSA studies with in vitro synthesized Pax6b protein (Prot) and oligonucleo-
ld be detected for P1+2+3, P4+5+6, P7+8, P9+10, P14 but not for P11, P12 and P13 (po-
297V. Arkhipova et al. / Developmental Biology 365 (2012) 290–302GFP, Fig. 3A). Based on theweak beta-cell speciﬁc reporter expression in
Tg[hb9ΔAB:GFP] embryos we further asked if the A-box contributes to
pancreas expression. To test this possibility we generated constructs
in which hsp:GFP was combined with either the A-box only (A+hsp:
GFP) or with PE and A-box (PE+A+hsp:GFP, Fig. 3A). In transient assays
54% of the PE+hsp:GFP (n=65), 37% of the PE+A+hsp:GFP (n=70)
but only 7% of the A+hsp:GFP (n=58) injected embryos showed
beta-cell speciﬁc expression (Fig. 3A). Consistent with an A-box inde-
pendent beta-cell speciﬁc regulation by the PE, pancreatic GFP expres-
sion in three out of four Tg[PE+hsp:GFP] lines was very similar to that
in the two Tg[PE+A+hsp:GFP] alleles while it was missing in all three
Tg[A+hsp:GFP] alleles (Figs. 3D–F, Supplemental Table 2). Overall, the
data show that the PE, and in particular the distal half of the PE, plays
a critical role in beta-cell regulation and that the PE alone is sufﬁcient
for regulating beta-cell speciﬁc expression.
Direct binding of Pax6b and NeuroD to multiple sites within the hb9 PE
Bioinformatic analyses of the PE sequence revealed several poten-
tial binding sites for transcription factors with well described function
in early endocrine cell differentiation, including consensus sequences
for Pax6 (Epstein et al., 1994; Zhou et al., 2002), E-box-binding pro-
teins such as Ngn3/NeuroD, and RAR (Mangelsdorf and Evans, 1995),
among others. For our initial studies we focused on the endocrine pro-
genitor factors Pax6b and NeuroD, for which 14 and 2 potential bind-
ing sites were found in the PE, respectively (Fig. 4A). To determine if
these consensus sites are recognized by the corresponding transcrip-
tion factors, we ﬁrst tested direct binding in electrophoretic mobility
shift assay (EMSA) with in vitro translated proteins and radioactively
labelled synthetic double-stranded oligonucleotides. To conﬁrm theFig. 5. Pax6b but not NeuroD is sufﬁcient to induce endodermal hb9 expression. (A) Schemat
mRNA encoding either Cas alone or a mixture of mRNAs encoding Cas together with NeuroD
hybridisation. (B–E) Expression of hb9mRNA in uninjected control embryos (B) and in emb
pax6bmRNA injected embryos (D) show ectopic hb9 signals. Signals in posterior notochord (
(C), and cas/neuroD (E) injected embryos correlate with the developmental delay caused by
controlled by PE-containing (Tg[hb9:GFP]ml2 in F–H) or PE-deleted (Tg[hb9ΔNheI:GFP] in I) hb
(G) show no gfp signals while injection of cas/pax6b mRNA results in a robust gfp induction
by Pax6b is PE-dependent.speciﬁcity of the observed interaction, we performed competition as-
says with unlabeled self-competitors and also analysed whether the
translated proteins recognized mutated consensus motifs.
To test NeuroD binding activities, the potential binding sites (E-
box motifs E1 and E2) were incubated with a mixture of NeuroD and
its dimerization partner E47 (Fig. 4B). We found that NeuroD/E47 het-
erodimers bind to both E-boxes and that this interaction is speciﬁc, as
NeuroD/E47 bound neither of the mutated E-boxes and unlabeled
self-competitors efﬁciently prevented interaction with the labelled
probes.
A slightly different strategywas used to test the 14 Pax6 paired box
consensus sites (termed P1–P14). As ten of these sites are separated
from their next neighbours by less than 12 nucleotides, we not only
used DNA oligos containing individual paired box consensus sites
but in some cases also oligos with additional neighbouring consensus
sites (Fig. 4C). The EMSA studies revealed strongest signals for the ol-
igonucleotides containing the most distal binding sites (P1+2+3) and
slightly weaker signals for P4+5+6, P7+8, P9+10 and P14. The poten-
tial binding sites P11, P12 and P13 were not recognized by Pax6b pro-
tein (Fig. 4C). Notably, all Pax6b-interacting oligonucleotides
showed a similar shift independent of whether one, two or three po-
tential Pax6 binding sites were present on the oligonucleotides. We
therefore reasoned that a single Pax6b protein binds each oligonucle-
otide. EMSA studies with mutated versions of P1+2+3 and P9+10 re-
veal different binding afﬁnities for the neighbouring Pax6 consensus
motifs, which could explain these results (Supplemental Fig. 3). In
particular we ﬁnd that P3 and P9 are dispensable for efﬁcient binding
to Pax6bwhile intact P1+2 and P10 sites are required for efﬁcient com-
petitionwith labelled P1+2+3 and P9+10, respectively (Supplemental
Fig. 3). As steric hindrancemight prevent simultaneous binding of twoic of the induction experiment: One cell of a 16–32 cell embryo stage was injected with
or Pax6b. Injected embryos were ﬁxed 8 h later (9 hpf) and analysed by mRNA in situ
ryos injected with cas (C), cas/paxb6 (D) and cas/neuroD (E) mRNA. Note that only cas/
bracket in B, C, E) represent endogenous hb9 expression, while reduced signals in the cas
the injection. (F–I) Expression of gfp mRNA in transgenic reporter lines in which gfp is
9 promoter-sequences. Uninjected (F) and cas-mRNA injected Tg[hb9:GFP]ml2 embryos
(H). Lack of gfp signals in cas/pax6b injected Tg[hb9ΔNheI:GFP] shows that gfp induction
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gest efﬁcient interaction of Pax6b with either P1 or P2 and with P10.
In summary, our EMSA data show that at least two transcription
factors with functions in endocrine progenitors, Pax6b and NeuroD,
can directly bind to the binding sites in the hb9 PE. Furthermore,
they reveal that the sequences with highest in vitro binding afﬁnity
for these proteins are localized in the distal part of PE, which is most
critical for beta-cell speciﬁc expression as based on our promoter
analyses.Ectopic induction of hb9 expression by Pax6b but not by NeuroD
Next we tested if overexpression of Pax6b and NeuroD encoding
mRNA is sufﬁcient to induce expression of either hb9 mRNA in wild
type embryos or gfp mRNA in our transgenic reporter lines. In order
to target the injected mRNA speciﬁcally to endoderm we took advan-
tage of a previously described approach for cell-autonomous induc-
tion of endoderm by Casanova/Sox32 (Kikuchi et al., 2001; Stafford
et al., 2006). In these experiments, a mixture of mRNAs encoding Cas
together with Pax6b or NeuroD and the lineage tracer nucRFP (data
not shown)was injected into a single-cell of 16–32 cell stage embryos
(Fig. 5A). Due to Cas activity, the progeny of the injected cells adopted
an endodermal fate which can then be analysed for hb9 or gfp mRNA
expression. Based on the short half-life of injected mRNA we choose
9 hpf for the ﬁxation of embryos. Our analyses revealed ectopic activa-
tion of hb9 in 63% (n=11, Figs. 5B–D, Supplemental Table 3) of the
pax6b mRNA injected embryos while neuroD mRNA had no effect
(n=13, Fig. 5E, Supplemental Table 3). To test if the Pax6b responsive
elements are present on the 3.1 kb promoter fragment, we next
injected the cas/pax6bmixture into Tg[hb9:GFP]ml2 transgenic embry-
os. These embryos showed robust expression of GFP protein as well as
gfp mRNA, while non-injected embryos as well as embryos injected
only with cas mRNA were gfp negative (Figs. 5F–H, Supplemental
Table 3). To clarify whether Pax6b responsiveness requires the PE,
we next injected pax6b/cas mRNA in Tg[hb9ΔNheI:GFP] transgenicFig. 6. hb9 expression is initiated but not maintained in Pax6b deﬁcient embryos. (A–F) Expr
(pancreas in B, D, F) of uninjected wild type (wt) embryos (A, B) and embryos injected wit
duced in pax6b but not in neuroDmorphants while motoneuron speciﬁc expression in the sa
Scale bars in all ﬁgures correspond to 20 μm. (G) Number of hb9 positive cells in the pancrea
neuroD morphants 0.19429, p-value for pax6b morphants 0.00467). (H–O) hb9 expression in
M), 30 hpf (J, N) and 35 hpf (K, O). Note that hb9 expression in pancreas (white arrowhead)
arrow) is not affected. Embryos are shown in lateral view with anterior to the left. Scale baembryos, in which the PE is missing. No gfp expression could be ob-
served in these embryos (Fig. 5I). Altogether, these data show that
Pax6b is sufﬁcient to activate endoderm speciﬁc hb9 expression and
that this activation is mediated through the PE.Pax6b is required for maintenance of hb9 expression in beta-cells
To test whether NeuroD and Pax6b are required for endogenous
regulation of pancreas-speciﬁc hb9 expression we performed knock-
down analyses with published morpholinos. We used a pax6b splicing
morpholino which has been shown to cause loss of insulin expression
(Verbruggen et al., 2010) and a neuroD morpholino that was used to
study neuroD function of the lateral line organ (Sarrazin et al., 2006).
Analyses of 24 hpf embryos injected with neuroD morpholino
revealed no difference in the staining intensities or the number of
hb9 expressing pancreatic cells between neuroD morphants (19.2
cells/embryo, n=5) and wild type (wt) embryos (20.8 cells/embryo,
n=5) (Figs. 6A–D, G). Together with the gain-of-function analyses,
this suggests that NeuroD is neither required nor sufﬁcient for early
hb9 regulation.
In contrast, pax6b morphants showed a reduced number of hb9
expressing pancreatic cells (14.3 cells/embryo, n=9) and expression
levels per cell appear much weaker as revealed by comparing staining
intensities in the spinal cord and the pancreas of morphants and wild
type embryos (Figs. 6A, B, D, F, G). We further noted that pax6b mor-
pholino had only a minor effect on the pancreatic GFP protein expres-
sion levels in 24 hpf injected Tg[hb9:GFP]ml2 embryos (data not
shown). GFP is a very stable protein that remains in the cells even
when mRNA expression has stopped. We therefore reasoned that
the difference between the GFP protein and hb9 mRNA expression
levels in the beta-cells of 24 hpf pax6bmorphants could indicate a de-
fect in maintenance rather than induction of hb9 mRNA expression.
To test this, we followed hb9 expression and gfp mRNA in pax6b−/−
mutants from 18 hpf until 36 hpf (Figs. 6H–O, Supplemental Fig. 4).
At 18 hpf, hb9 expression in pax6b mutants is similar to that in wildession of hb9mRNA at 24 hpf in motoneurons (MN in A, C, E) and in the pancreatic islet
h neuroD (C, D) or pax6b morpholinos (E, F). Note that pancreatic hb9 expression is re-
me embryos is not affected. Embryos are shown in dorsal view with anterior to the left.
s of the wild type (wt), neuroD (MOneuroD) and pax6b (MOpax6b) morphants. (p-value for
wild type embryos (H, I, J, K) and pax6bmutants (L, M, N, O) at 18 hpf (H, L), 25 hpf (I,
decreases during development in mutants, whereas expression in motoneurons (white
rs in all ﬁgures correspond to 20 μm.
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Pax6b leads to the progressive reduction of hb9 expression in the pan-
creas (Figs. 6I, J, M, N). At 35 hpf no hb9 expression could be detected
in the endocrine pancreas (Figs. 6K, O). Importantly, at all stages ana-
lysed, motoneuron hb9 expression in pax6b−/−mutants was not af-
fected (Figs. 6H–O), revealing the speciﬁc role for Pax6b in regulation
of hb9 in the endocrine pancreas. Taken together, our results show
that Pax6b is required for maintenance but not initiation of hb9
expression.Induction of pancreatic hb9 expression requires E-box elements
While our studies suggest that NeuroD is not required for hb9 ex-
pression, they do not exclude the option that other bHLH proteins
regulate hb9 transcription through interaction with the two E-box el-
ements. A promising candidate for such factors is Ngn3 even though
ngn3 expression has not been reported in the early zebraﬁsh pancreas
(Kinkel and Prince, 2009; Zecchin et al., 2007). As expression levels of
ngn3may be below detection limit, we used a genetic approach to de-
termine ngn3 functions in embryonic hb9 transcription. However,
comparison of pancreatic hb9 or gfp expression revealed no signiﬁ-
cant differences between uninjected embryos, and embryos that
were injected with ngn3 morpholinos alone or with a combination
of neuroD and ngn3 morpholinos (Figs. 7A, D, C, F, G, data not
shown). This shows that neither ngn3 nor neuroD is required for
early pancreatic hb9 expression.
To test more directly for a function of the E-boxes we asked if they
are required for beta-cell speciﬁc reporter expression. Injection of the
hb9Em:GFP reporter construct in which both E-boxes were mutated by
site-directed mutagenesis resulted in only 1 out of 120 embryos
(0.8%) showing GFP expression in the pancreas. Further, analyses of
two hb9Em:GFP transgenic ﬁshlines revealed a complete absence of
GFP expression in the endocrine pancreas (Fig. 7I). As motoneuron
speciﬁc expression in these embryos was similar to that of Tg[hb9:
GFP]ml2 embryos, our data suggest a speciﬁc requirement of one or
several unspeciﬁed E-box-binding factors during initiation of beta-
cell speciﬁc hb9 expression.Fig. 7. E-box binding proteins but not Ngn3 and NeuroD are required for beta-cell speciﬁc h
A–C) and in the pancreatic islet (pancreas in D–F) of uninjected wild type (wt) embryos (A
pholinos (C, F). Different focus planes of the same embryos are shown in dorsal view with an
n=21), ngn3 (MOngn3, n=32) and ngn3/neuroD (MOngn3/neuroD, n=22) morphants at 24 h
were mutated by site-directed mutagenesis (origin and mutated sequences are shown with
of transient reporter assays in which a single embryo out of 120 GFP positive embryos (n) sh
embryos at 28 hpf in whole embryos and in embryos stained with antibodies for GFP (green
ages shown are confocal image projections with an overlay at the right. Scale bar corresponDiscussion
Vertebrate hb9 genes show conserved expression and function in
early beta-cell maturation. While hb9 genes have been subject to sev-
eral promoter analyses, the enhancer elements regulating pancreas
speciﬁc expression have not been identiﬁed. By using transient and
stable transgenic reporter assays, we now show that in zebraﬁsh, a
non-conserved 5 prime upstream region of 478 bp is sufﬁcient and
required for targeting expression speciﬁcally to beta-cell progenitors.
We further identify NeuroD and Pax6b as transcription factors that di-
rectly bind in vitro to this enhancer element and we present in vivo
gain and loss-of-function analyses that suggest essential function of
currently not speciﬁed E-box-binding factors and of Pax6b during ini-
tiation and maintenance of beta-cell speciﬁc expression of hb9,
respectively.
hb9 regulation by conserved and non-conserved enhancer elements
Hb9 genes throughout vertebrates show complex embryonic ex-
pression in various tissues of endodermal, ectodermal and mesoder-
mal origin (Arber et al., 1999; Broihier and Skeath, 2002; Ferrier et
al., 2001; Grapin-Botton et al., 2001; Ross et al., 1998; Tanabe et al.,
1998; Thaler et al., 1999; Wendik et al., 2004). Here we show that
3.1 kb of zebraﬁsh hb9 upstream genomic DNA is sufﬁcient to recapit-
ulate the conserved expression of hb9 in motoneurons and in differ-
entiating beta-cells. These sequences include two highly conserved
non-coding motifs, the A- and B-box. Our data show that in zebraﬁsh,
the B-box mediates reporter expression in motoneurons and some
ventral interneurons while the A-box is dispensable for embryonic
hb9 regulation. Similar conclusions have been drawn from the ana-
lyses of the A- and B-boxes of the mouse hb9 promoter, in which
three copies of the B-box fused to a minimal promoter were sufﬁcient
to regulate expression in motoneurons, while a corresponding con-
struct with three copies of the A-box failed to induce any speciﬁc re-
porter expression (Nakano et al., 2005). Interestingly, motoneuron
speciﬁc hb9 regulation in mouse also involves a second mammal-
speciﬁc element termed MNE, which has a distinct mode of molecular
activity as compared to the B-box (Lee and Pfaff, 2003; Lee et al.,b9 expression. (A–F) Similar expression of hb9mRNA at 24 hpf in motoneurons (MN in
, D) and embryos injected with ngn3 (B, E) or a combination of ngn3 and neuroD mor-
terior to the left. (G) Countings of hb9 positive cells in the pancreas of the wild type (wt,
pf. (H) Schematic drawing of the hbEm:GFP construct in which both E-boxes (red line)
consensus sequences being underlined). Numbers on the right summarize the results
owed reporter expression within the pancreas (P). (I) GFP expression in Tg[hb9Em:GFP]
, expression corresponds to motor axons), insulin (blue) and islet (red). The right im-
ds to 100 μm (live embryo in I) and 20 μm (A–F, confocal images in I).
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Hox/Pbx factors to mediate anterior–posterior positional information
(Nakano et al., 2005), the MNE is regulated by basic helix–loop–helix
(bHLH) and Lim-homeodomain (Lim-HD) transcription factors that
integrate signals of dorsal–ventral patterning and cell differentiation
(Lee and Pfaff, 2003; Lee et al., 2004; Lee et al., 2008). The highly con-
served function of Lim-HD, bHLH and Hb9 proteins in motoneuron
differentiation implies that molecular interactions between these fac-
tors are not restricted to mammals (Briscoe et al., 2000; Lee and Pfaff,
2003; Lee et al., 2004; Shirasaki and Pfaff, 2002; Zhou and Anderson,
2002), even though MNE related sequences are not detectable in non-
mammalian system. Our transient reporter assays reveal that a criti-
cal region of 300 bp, including the B-box, is required for motoneuron
speciﬁc expression in zebraﬁsh (compare ΔASphI and ΔABAvrII in Fig. 2,
Supplemental Fig. 1). While low sequence conservation may prevent
bioinformatics-based detection of MNE related sequences, it is still
possible that this critical region similarly receives combined regulato-
ry input from bHLH, Lim-HD and Hox/Pbx factors. Alternatively, in
non-mammalian organisms, the regulatory function of the MNE may
be located to the enhancer of the hb9 paralog mnr2, which is missing
in mammals (Wendik et al., 2004). Preliminary sequence analyses of
the twomnr2 genes in zebraﬁsh did not provide evidence for MNE re-
lated sequences and it will be interesting to determine how con-
served factors which regulate the MNE, such as the bHLH proteins
Olig2, Ngn2, NeuroD and the lim-HD factors Isl1/2 and Lhx3 (Lee
and Pfaff, 2003), contribute to motoneuron speciﬁc hb9/mnr2 regula-
tion in non-mammalian organisms.
Recent high throughput analyses of cis-regulatory elements came
to the conclusion that a lot of enhancer elements are not conserved
between vertebrates and this includes both activator and repressor el-
ements (Birney et al., 2007; McGaughey et al., 2009; Roh et al., 2007).
Consistent with this, we were unable to recapitulate all sites of endog-
enous hb9 mRNA expression with our transgenic hb9-reporter lines
and most transgenic lines, including the initially reported Tg[hb9:
GFP]ml2 and Tg[hb9:GFP]ml3 (Flanagan-Steet et al., 2005; Kimmel and
Meyer, 2010) show ectopic reporter expression in hb9-negative tis-
sues such as hindbrain and eye. This shows that hb9 is regulated by ad-
ditional activating and repressing elements outside of the analysed
3.1 kb region. As these more distal sequences lack homology to corre-
sponding regions of other vertebrate hb9 genes, this suggests func-
tions for additional non-conserved element in hb9 regulation.
Among those, the as-yet unidentiﬁed enhancer regulating expression
in caudal structures and notochord is ofmajor interest when consider-
ing the connection of human HLXB9 and Currarino syndrome. In these
patients, reduced HLXB9 function resulting from loss of one HLXB9 al-
lele is thought to cause formation of caudal teratomas, which in conse-
quence lead to sacral agenesis (Ross et al., 1998).
Beta-cell speciﬁc regulation by the non-conserved PE
Previous analyses of the mouse hb9 gene failed to detect a beta-
cell enhancer in a 9 kb fragment upstream of the hb9 gene (Arber et
al., 1999; Nakano et al., 2005; Wichterle et al., 2002). Notably, this
fragment contained the A-box at the most distal position. In our stud-
ies we localize the zebraﬁsh hb9 beta-cell enhancer to a 478 bp se-
quence directly distal to the A-box, thus to a region that was not
analysed in mouse. Our transient and transgenic reporter analyses
demonstrate that these 478 bp, termed PE, are required and sufﬁcient
for targeting expression to beta-cell progenitors. While sequence
alignments of the PE reveal no obvious homologies to the Medaka
hb9 gene, we also found that the zebraﬁsh hb9:GFP construct is sufﬁ-
cient to regulate beta-cell speciﬁc expression in hb9:gfp transgenic
Medaka embryos (D. Meyer, unpublished data). This demonstrates
that the regulatory activity of this early beta-cell enhancer is con-
served, at least in ﬁsh. The lack of pancreas speciﬁc GFP-expression
in Tg[hb9Δ1:GFP] but not in Tg[hb9Δ2:GFP] further suggests that thedistal part of the PE contains essential elements while the proximal
part is dispensable for beta-cell expression. Consistent with these
data, the majority of the EMSA-conﬁrmed Pax6b binding sites and
both E-boxes localize to the distal half of the PE. Nevertheless, the dis-
tal part without the A- and B-box containing sequences is not sufﬁ-
cient to trigger beta-cell speciﬁc reporter expression. Possibly, the
proximal half of the PE and the ﬂanking conserved sequences both
contain functionally redundant regulatory elements that interact
with the distal elements.
Molecular regulation of the PE
Our studies revealed speciﬁc requirements of E-box-binding fac-
tors and Pax6 during initiation and maintenance of beta-cell speciﬁc
hb9 expression. In particular, we show that the PE contains two E-
boxes and multiple Pax6-binding sites that interact in vitrowith Neu-
roD/E47 and Pax6b proteins, respectively. From the 14 potential
Pax6-type paired box binding sites revealed by bioinformatic ana-
lyses, at least ﬁve are recognized by Pax6b protein in vitro. Interest-
ingly, four of these Pax6b-interacting sequences contain two or
three nearly adjacent Pax6 consensus motifs and one of these double
Pax6 consensus motifs has an intervening E-box. The functional rele-
vance of these clusters is unclear, in particular as the presence of mul-
tiple Pax6 consensus motifs did not result in binding of multiple
Pax6b proteins.
In order to determine the biological role of the E-boxes and the
Pax6 binding sites, we tested if loss or gain of protein function affects
hb9 expression. We show that the E-boxes are essential to initiate
beta-cell speciﬁc reporter expression in hb9:GFP transgenic embryos
and that this induction is initiated independent of the E-box-
binding proteins NeuroD and Ngn3. Consistent with the previously
reported lack of ngn3mRNA expression in the early zebraﬁsh pancre-
as (Kinkel and Prince, 2009; Moro et al., 2009), we also ﬁnd that ngn3
is dispensable for early beta-cell development in zebraﬁsh. The re-
sults reveal major difference between mouse and zebraﬁsh ngn3
functions in pancreas development and they imply that in zebraﬁsh
at least one additional E-box binding factor acts upstream or in paral-
lel to NeuroD during beta-cell differentiation. Notably, in human only
a few of the homozygous NGN3 missense mutations are associated
with neonatal diabetes as an indicator for missing beta-cells (Rubio-
Cabezas et al., 2011). While the non-diabetes phenotypes could result
from hypomorphic NGN3 alleles it is also possible that differentiation
of beta-cells in human may require additional to-be identiﬁed E-box-
binding factors similar to the situation in zebraﬁsh.
Our data further suggest that the paired-box binding sites within
the PE mediate Pax6b-dependent hb9 transcriptional activation. We
show that injection of pax6b mRNA results in ectopic induction of
hb9 mRNA and of gfp mRNA in hb9:GFP transgenes, and that this in-
duction is PE dependent. The data strongly suggest a direct regulation
of the PE by Pax6b, while they also reveal that Pax6b is not required
for the initiation but for the maintenance of pancreatic hb9 expres-
sion. Interestingly, almost no beta-cells are observed in pax6b-
mutants showing that besides Hb9, other factors are probably acting
downstream from Pax6b to drive the differentiation of beta-cells.
Conclusion
Currently, the vertebrate insulin promoter is the major model for
studying the molecular basis of beta-cell speciﬁc transcription. Our
studies now introduce the hb9-PE element as a novel model not
only for studies of the regulation of early beta-cell speciﬁc transcrip-
tion, but also for studying the molecular control of beta-cell differen-
tiation. Our studies further revealed interactions of two classes of
transcription factors with this novel beta-cell speciﬁc enhancer. We
show that a currently unspeciﬁed combination of E-box-binding pro-
teins is required to initiate PE based expression and that Pax6b is a
301V. Arkhipova et al. / Developmental Biology 365 (2012) 290–302potent activator of this enhancer that is required to maintain hb9 ex-
pression. Our analyses suggest that these genes have independent
function during initial steps of beta-cell differentiation in zebraﬁsh.
As Pax6b and Hb9 are both required to initiate expression of insulin
this raises the question whether the observed function of Pax6b in
maintaining endocrine hb9 expression represents a conserved cross-
regulation between two beta-cell fate-regulating transcription fac-
tors. Previously reported interactions between Pax6 and various co-
factors in non-pancreatic tissues provide interesting opportunities
to address questions on the molecular regulation of beta-cell restric-
tion of transcription in the context of early induction in beta-cell pro-
genitors or maintenance after maturation. Reported interactions of
Pax6 with members of the Sox and Ets family of transcription factors
and with the chromatin remodelling factor Brg1 provide interesting
novel links for future studies on the genetic and epigenetic regulation
of beta-cell restricted expression (Cvekl et al., 2004; Kamachi et al.,
2001; Yang et al., 2006).
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